955979-02-9 (2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde,Thieno3,2-dpyrimidine-6-carboxaldehyde, 2-chloro-7-methyl-4-(4-morpholinyl)-)

CAS号:
955979-02-9
中文名称:
2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde
英文名称:
Thieno3,2-dpyrimidine-6-carboxaldehyde, 2-chloro-7-methyl-4-(4-morpholinyl)-
分子式:
C12H12ClN3O2S
分子量:
297.760580062866

2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde(955979-02-9)名称与标识符

名称

中文别名:
2-氯-7-甲基-4-吗啉代吡啶并[3,2-D]嘧啶-6-甲醛;2-氯-7-甲基-4-吗啉噻吩并[3,2-d]嘧啶-6-甲醛;2-chloro-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidine-6-carbaldehyde;
英文别名:
2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde;2-Chloro-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidine-6-carboxaldehyde (ACI);2-Chloro-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine-6-carboxaldehyde;2-Chloro-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidine-6-carbaldehyde;DTXSID001143316;2-Chloro-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidine-6-carboxaldehyde;BCP14844;CS-M2503;955979-02-9;AKOS037649669;DA-26400;2-Chloro-7-methyl-4-morpholinothieno-[3,2-d]pyrimidine-6-carbaldehyde;PNFPJVXECCRKQD-UHFFFAOYSA-N;Thieno[3,2-d]pyrimidine-6-carboxaldehyde, 2-chloro-7-methyl-4-(4-morpholinyl)-;2-chloro-7-methyl-4-morpholin-4-yl-thieno[3,2-d]pyrimidine-6-carbaldehyde;CS-13126;SCHEMBL190265;

标识符

InChIKey:
PNFPJVXECCRKQD-UHFFFAOYSA-N
Inchi:
1S/C12H12ClN3O2S/c1-7-8(6-17)19-10-9(7)14-12(13)15-11(10)16-2-4-18-5-3-16/h6H,2-5H2,1H3
SMILES:
O=CC1=C(C)C2N=C(N=C(C=2S1)N1CCOCC1)Cl

2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde(955979-02-9)物化性质

计算特性

  • 精确分子量 : 297.0338755g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 2
  • 同位素质量 : 297.0338755g/mol
  • 重原子数量 : 19
  • 复杂度 : 343
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.5
  • 拓扑分子极性表面积 : 83.6Ų

2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde(955979-02-9)推荐厂家 更多厂家(4)

2-chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde(955979-02-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Process for the preparation of (S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one (GDC-0980)
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
A Practical, Protecting-Group-Free Synthesis of a PI3K/mTOR Inhibitor
Tian, Qingping; Hoffmann, Ursula; Humphries, Theresa; Cheng, Zhigang; Hidber, Pirmin; et al, Organic Process Research & Development, 2015, 19(3), 416-426
合成路线:1 步
反应条件:
参考文献:
Dual kinase-bromodomain inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of fused heterocyclic compound derivative as PARP-1/PI3K dual-target inhibitor and used for the treatment of tumors
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer
Wu, Zhengyang; Bai, Ying; Jin, Jiaming; Jiang, Teng; Shen, Hui; et al, European Journal of Medicinal Chemistry, 2021, 217,
合成路线:1 步
反应条件:
参考文献:
Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
Sutherlin, Daniel P.; Bao, Linda; Berry, Megan; Castanedo, Georgette; Chuckowree, Irina; et al, Journal of Medicinal Chemistry, 2011, 54(21), 7579-7587
合成路线:1 步
反应条件:
参考文献:
Preparation of thienopyrimidines and furopyrimidines as lipid kinase inhibitors for treating cancer and other diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of thienopyrimidine derivatives as PI3 kinase inhibitors
, World Intellectual Property Organization, , ,